Updated:
Seaside Ventures
Seaside Ventures is a Boulder-based VC that writes $250K checks into early-stage health and wellness startups targeting proactive, personalized medicine.
Seaside Ventures
Fueling the Future of Health & Wellness: Backing innovations that enhance health, boost happiness, and elevate quality of life.
General information
Firm type
Venture Capital
Year founded
2017
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Boulder
Corporate office
Boulder, CO, United States
Additional offices
San Francisco, CA, United States · New York, NY, United States
Principals
Harrison Valner
Partner
Ryan Roddy
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Seaside Ventures?
Partners Harrison Valner and Ryan Roddy lead the firm and sign off on investment decisions. The website names them as the primary operators. No external team size has been disclosed.
What is Seaside Ventures' typical check size and stage?
Seaside invests from the idea stage through seed and writes checks of $250,000. The firm prefers to get involved on the ground floor and works with founders to build companies toward commercialization.
How does the Seaside Ventures syndicate work?
The firm operates a public syndicate program alongside its core fund. This allows external angels and other investors to participate in Seaside’s deal flow on a recurring basis, rather than committing to a single closed-end fund.
What is Seaside Ventures' investment thesis?
Seaside defines its thesis as 'Medicine 3.0,' backing science-driven health and wellness technologies that shift care from reactive treatment to proactive prevention. The firm seeks products with defensible innovation and a clear path to commercial scale.
Does Seaside Ventures invest internationally?
Currently, the firm invests only in the United States, Canada, and Europe, with plans for a broader global footprint in the future.
Which sectors does Seaside Ventures avoid?
Seaside does not list explicit exclusions, but its portfolio is absent of traditional biotech drug discovery, enterprise SaaS outside of health, and hardware not linked to a human wellness outcome.
How does Seaside Ventures support portfolio companies beyond capital?
The firm emphasizes bridging the gap between scientific validation and commercialization. Team members actively assist with go-to-market strategy, brand visibility, and distribution partnerships to help startups transition from lab to market.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: